Effects of depleting the essential central metabolic enzyme fructose-1,6-bisphosphate aldolase on the growth and viability of Candida albicans: implications for antifungal drug target discovery.
about
Glycolytic and Non-glycolytic Functions of Mycobacterium tuberculosis Fructose-1,6-bisphosphate Aldolase, an Essential Enzyme Produced by Replicating and Non-replicating BacilliA Noncompetitive Inhibitor for Mycobacterium tuberculosis ’s Class IIa Fructose 1,6-Bisphosphate AldolaseGlobal analysis of the evolution and mechanism of echinocandin resistance in Candida glabrataGlutathione utilization by Candida albicans requires a functional glutathione degradation (DUG) pathway and OPT7, an unusual member of the oligopeptide transporter family.Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans.Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it.Structural and functional characterization of methicillin-resistant Staphylococcus aureus's class IIb fructose 1,6-bisphosphate aldolase.Genome-wide Analysis of Mycoplasma hominis for the Identification of Putative Therapeutic Targets.Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia.Molecular and proteomic analyses highlight the importance of ubiquitination for the stress resistance, metabolic adaptation, morphogenetic regulation and virulence of Candida albicansMetabolism in fungal pathogenesis.Vaccine and monoclonal antibody that enhance mouse resistance to candidiasisProteomics of Fusarium oxysporum race 1 and race 4 reveals enzymes involved in carbohydrate metabolism and ion transport that might play important roles in banana Fusarium wilt.Mutations in alternative carbon utilization pathways in Candida albicans attenuate virulence and confer pleiotropic phenotypesIntegrative Model of Oxidative Stress Adaptation in the Fungal Pathogen Candida albicans.Identification of promising host-induced silencing targets among genes preferentially transcribed in haustoria of Puccinia.A feast for Candida: Metabolic plasticity confers an edge for virulence.Role of acetyl coenzyme A synthesis and breakdown in alternative carbon source utilization in Candida albicans.Potential therapeutic drug target identification in Community Acquired-Methicillin Resistant Staphylococcus aureus (CA-MRSA) using computational analysis.Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels.Candida albicans uses multiple mechanisms to acquire the essential metabolite inositol during infection.Identification of sumoylation targets, combined with inactivation of SMT3, reveals the impact of sumoylation upon growth, morphology, and stress resistance in the pathogen Candida albicans.Molecular modeling, dynamics studies and virtual screening of Fructose 1, 6 biphosphate aldolase-II in community acquired- methicillin resistant Staphylococcus aureus (CA-MRSA)ModEnzA: Accurate Identification of Metabolic Enzymes Using Function Specific Profile HMMs with Optimised Discrimination Threshold and Modified Emission Probabilities.Integrated proteomics, genomics, metabolomics approaches reveal oxalic acid as pathogenicity factor in Tilletia indica inciting Karnal bunt disease of wheat.Comparative Proteomic Analysis of Candida albicans and Candida glabrata
P2860
Q27674487-2A4AB47D-BA0F-4A7E-AA4A-A455F059C50CQ27680863-81A3BF97-B59F-4487-8202-2304DAE6E4B2Q28483785-F6DE37C6-0FD1-4EB4-82E9-EDA8498A9540Q31034172-1D481F3E-3E7D-4E81-860E-84964811B75CQ33509505-83277142-441F-41AC-8772-F4E3E7C31B52Q33928824-B5EB6B79-4002-4765-A417-2A417F823AA6Q34680207-AE08529C-8CC7-4CA9-812F-E57A075984B7Q34680309-0390B577-D74B-4713-B908-43E8BC720446Q34750701-C244C89A-861F-4FEE-8F6F-9E69C4B8519CQ34886777-8E5EB041-1CEB-4167-A4BF-E2181C99E0DFQ34930405-C50C710B-9EE5-4196-993E-1BE9BBF2C420Q35271053-052172FE-8D34-4576-AFFD-8BDC1E7A3357Q35474433-17188F8A-96B8-4CE9-AF18-838C88B636B0Q35636503-2C8E7C35-B141-4BF6-B1CE-F70C42B7FDFBQ35774249-9EA7AB74-10AC-4EC2-BB28-BAAAB2C140DEQ35914034-A4F74D60-7652-4BDE-A4F9-40C333389F73Q36275756-E403C1CA-FDEB-43A6-91FD-D7F980CCD589Q36939045-1C8CE048-2031-47DD-B0D7-1DF6F107DAB3Q38051296-FFAF7A3F-EB54-4B1D-B068-ABB4D3D34240Q38236582-5D78EBEF-671E-4668-9221-EEB700F73761Q39023515-2B20560A-AD4F-4797-8ACA-6A8FBE4F3D06Q41864652-D35D5371-2562-4FCF-BA79-157F99C778CAQ41915311-A57C94C4-4A41-452C-9E14-992D68A0DC26Q42599526-D8E264BF-498B-4930-948C-CF6A9F2D2BE5Q54937099-16CF3D37-1306-4869-B737-FB37D19518B3Q58482730-B933ED75-E0D8-4E9B-A63F-41BA3457B05B
P2860
Effects of depleting the essential central metabolic enzyme fructose-1,6-bisphosphate aldolase on the growth and viability of Candida albicans: implications for antifungal drug target discovery.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effects of depleting the essen ...... ifungal drug target discovery.
@ast
Effects of depleting the essen ...... ifungal drug target discovery.
@en
Effects of depleting the essen ...... ifungal drug target discovery.
@nl
type
label
Effects of depleting the essen ...... ifungal drug target discovery.
@ast
Effects of depleting the essen ...... ifungal drug target discovery.
@en
Effects of depleting the essen ...... ifungal drug target discovery.
@nl
prefLabel
Effects of depleting the essen ...... ifungal drug target discovery.
@ast
Effects of depleting the essen ...... ifungal drug target discovery.
@en
Effects of depleting the essen ...... ifungal drug target discovery.
@nl
P2860
P356
P1433
P1476
Effects of depleting the essen ...... ifungal drug target discovery.
@en
P2093
Alexandra Rodaki
P2860
P304
P356
10.1128/EC.00115-06
P577
2006-08-01T00:00:00Z